Carnegie Lake Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.45M Hold
23,345
3.15% 6
2026
Q1
$8.21M Hold
23,345
3.26% 5
2025
Q4
$7.64M Hold
23,345
2.91% 7
2025
Q3
$6.59M Hold
23,345
2.54% 8
2025
Q2
$6.52M Hold
23,345
2.58% 6
2025
Q1
$7.27M Hold
23,345
2.95% 6
2024
Q4
$6.08M Hold
23,345
2.46% 6
2024
Q3
$7.52M Buy
+23,345
New +$7.64M 2.98% 7

Other funds holding AMGN

Carnegie Lake Advisors's AMGN Position: Q2 2026 in Review

Carnegie Lake Advisors held its Amgen (AMGN) position steady in Q2 2026 at 23,345 shares worth $8.45M. The position accounts for 3.15% of the portfolio, ranked #6.

Carnegie Lake Advisors first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Carnegie Lake Advisors held 23,345 shares of Amgen worth $8.45M as of Q2 2026.
  • Carnegie Lake Advisors left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 3.15% of Carnegie Lake Advisors's portfolio in Q2 2026, its #6 holding.
  • Carnegie Lake Advisors first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Carnegie Lake Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.